These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10028378)

  • 1. Age-depending effects of methotrexate treatment on systemic bone turnover in experimental adjuvant arthritis.
    Segawa Y; Tsuzuike N; Itokazu Y; Omata T; Inoue N; Aota S; Okazaki Y; Nakamura T
    Arzneimittelforschung; 1999 Jan; 49(1):38-43. PubMed ID: 10028378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats.
    Segawa Y; Yamaura M; Aota S; Omata T; Tuzuike N; Itokazu Y; Oka H; Tamaki H; Nakamura T
    Bone; 1997 May; 20(5):457-64. PubMed ID: 9145243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
    Rovensky J; Svík K; Stancíková M; Istok R
    J Rheumatol; 2003 Sep; 30(9):2027-32. PubMed ID: 12966611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of purified micronized flavonoid fraction (Detralex) on prophylactic treatment of adjuvant arthritis with methotrexate in rats.
    Rovenský J; Svík K; Rovenská E; Stvrtinová V; Stancíková M
    Isr Med Assoc J; 2008 May; 10(5):377-80. PubMed ID: 18605365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis.
    Morgan SL; Chen DT; Carlee J; Baggott JE
    J Rheumatol; 2004 Sep; 31(9):1693-7. PubMed ID: 15338486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination.
    Rovenský J; Stancíková M; Rovenská E; Stvrtina S; Stvrtinová V; Svík K
    Ann N Y Acad Sci; 2009 Sep; 1173():798-804. PubMed ID: 19758231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interleukin 1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats.
    Bendele A; Sennello G; McAbee T; Frazier J; Chlipala E; Rich B
    J Rheumatol; 1999 Jun; 26(6):1225-9. PubMed ID: 10381034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-bone resorption activity of deer antler aqua-acupunture, the pilose antler of Cervus korean TEMMINCK var. mantchuricus Swinhoe (Nokyong) in adjuvant-induced arthritic rats.
    Kim KH; Kim KS; Choi BJ; Chung KH; Chang YC; Lee SD; Park KK; Kim HM; Kim CH
    J Ethnopharmacol; 2005 Jan; 96(3):497-506. PubMed ID: 15619570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant induced arthritis.
    Suzuki Y; Nakagawa M; Masuda C; Ide M; Uehara R; Ichikawa Y; Mizushima Y
    J Rheumatol; 1997 Oct; 24(10):1890-5. PubMed ID: 9330928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
    Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
    J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium.
    Rovenský J; Svík K; Matha V; Istok R; Kamarád V; Ebringer L; Ferencík M; Stancíková M
    Ann N Y Acad Sci; 2005 Jun; 1051():570-81. PubMed ID: 16126997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague-Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management.
    Sengupta S; Arshad M; Sharma S; Dubey M; Singh MM
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):421-9. PubMed ID: 15876407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of combined methotrexate/chloroquine therapy in adjuvant-induced arthritis.
    Silva MA; Ishii-Iwamoto EL; Bracht A; Caparroz-Assef SM; Kimura E; Cuman RK; Bersani-Amado CA
    Fundam Clin Pharmacol; 2005 Aug; 19(4):479-89. PubMed ID: 16011736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: implication of distinct effect from suppression of inflammation.
    Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
    Int Immunopharmacol; 2005 Mar; 5(3):503-10. PubMed ID: 15683847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTX affects inflammation and tissue destruction differently in the rat AA model.
    Morgan SL; Baggott JE; Bernreuter WK; Gay RE; Arani R; Alarcón GS
    J Rheumatol; 2001 Jul; 28(7):1476-81. PubMed ID: 11469449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.
    Osterman T; Virtamo T; Laurén L; Kippo K; Pasanen I; Hannuniemi R; Väänänen K; Sellman R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1001-7. PubMed ID: 9023317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.